{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T06:20:54Z","timestamp":1792304454467,"version":"4.4.0"},"reference-count":28,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2016,1,8]],"date-time":"2016-01-08T00:00:00Z","timestamp":1452211200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["ijgo.org","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Gynecology & Obstetrics"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1016\/j.ijgo.2015.11.006","type":"journal-article","created":{"date-parts":[[2016,1,8]],"date-time":"2016-01-08T10:31:42Z","timestamp":1452249102000},"page":"356-358","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Non-hormonal interruption of incessant ovulation as a potential approach for ovarian cancer prevention"],"prefix":"10.1002","volume":"132","author":[{"given":"Mahmoud F.","family":"Fathalla","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2016,1,8]]},"reference":[{"issue":"(2)","key":"10.1016\/j.ijgo.2015.11.006-BIB0005|rf0005","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.ygyno.2013.11.030","article-title":"Ovarian cancer screening-current status, future directions","volume":"132","author":"Menon","year":"2014","journal-title":"Gynecol Oncol"},{"issue":"(7716)","key":"10.1016\/j.ijgo.2015.11.006-BIB0010|rf0010","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0140-6736(71)92335-X","article-title":"Incessant ovulation-a factor in ovarian neoplasia?","volume":"2","author":"Fathalla","year":"1971","journal-title":"Lancet"},{"issue":"(2)","key":"10.1016\/j.ijgo.2015.11.006-BIB0015|rf0015","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.jrhm.2015.06.002","article-title":"Women and the burden of human reproduction: an evolutionary perspective","volume":"1","author":"Fathalla","year":"2015","journal-title":"J Reprod Health Med"},{"issue":"(4)","key":"10.1016\/j.ijgo.2015.11.006-BIB0020|rf0020","first-page":"292","article-title":"Incessant ovulation and ovarian cancer-a hypothesis re-visited","volume":"5","author":"Fathalla","year":"2013","journal-title":"Facts Views Vis Obgyn"},{"issue":"(9609)","key":"10.1016\/j.ijgo.2015.11.006-BIB0025|rf0025","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S0140-6736(08)60167-1","article-title":"Ovarian cancer and oral contraceptives: collaborative reanalysis of data from 45 epidemiological studies including 23 257 women with ovarian cancer and 87 303 controls","volume":"371","author":"Collaborative Group on Epidemiological Studies of Ovarian Cancer","year":"2008","journal-title":"Lancet"},{"issue":"(3)","key":"10.1016\/j.ijgo.2015.11.006-BIB0030|rf0030","first-page":"130","article-title":"Ovarian cancer of tubal origin, incessant ovulation and implications for medical practice","volume":"2","author":"Fathalla","year":"2015","journal-title":"Am J Clin Exp Obstet Gynecol"},{"issue":"(1)","key":"10.1016\/j.ijgo.2015.11.006-BIB0035|rf0035","first-page":"279","article-title":"Committee opinion no. 620: salpingectomy for ovarian cancer prevention","volume":"125","author":"Committee on Gynecologic Practice","year":"2015","journal-title":"Obstet Gynecol"},{"issue":"(9834)","key":"10.1016\/j.ijgo.2015.11.006-BIB0040|rf0040","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.1016\/S0140-6736(11)61746-7","article-title":"The plight of nuns: hazards of nulliparity","volume":"379","author":"Britt","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.ijgo.2015.11.006-BIB0045|rf0045","first-page":"189","article-title":"Mechanisms and pathobiology of ovulation","volume":"67","author":"Murdoch","year":"2010","journal-title":"Soc Reprod Fertil Suppl"},{"issue":"(8)","key":"10.1016\/j.ijgo.2015.11.006-BIB0050|rf0050","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1093\/humrep\/del113","article-title":"Luteinized unruptured follicle syndrome: incidence and recurrence rate in infertile women with unexplained infertility undergoing intrauterine insemination","volume":"21","author":"Qublan","year":"2006","journal-title":"Hum Reprod"},{"issue":"(2)","key":"10.1016\/j.ijgo.2015.11.006-BIB0055|rf0055","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1093\/humrep\/dep424","article-title":"Oral administration of the cyclooxygenase-2 (COX-2) inhibitor meloxicam blocks ovulation in non-human primates when administered to simulate emergency contraception","volume":"25","author":"Hester","year":"2010","journal-title":"Hum Reprod"},{"issue":"(8)","key":"10.1016\/j.ijgo.2015.11.006-BIB0060|rf0060","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1093\/rheumatology\/39.8.880","article-title":"Non-steroidal anti-inflammatory drugs as a possible cause for reversible infertility","volume":"39","author":"Mendon\u00e7a","year":"2000","journal-title":"Rheumatology (Oxford)"},{"issue":"(3)","key":"10.1016\/j.ijgo.2015.11.006-BIB0065|rf0065","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.rbmo.2011.12.002","article-title":"Short-term, low-dose, non-steroidal anti-inflammatory drug application diminishes premature ovulation in natural-cycle IVF","volume":"24","author":"Kawachiya","year":"2012","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.ijgo.2015.11.006-BIB0070|rf0070","volume-title":"Contraceptive research and development: Looking to the future","year":"1996"},{"issue":"(5)","key":"10.1016\/j.ijgo.2015.11.006-BIB0075|rf0075","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1093\/humupd\/dmv026","article-title":"Novel contraceptive targets to inhibit ovulation: the prostaglandin E2 pathway","volume":"21","author":"Duffy","year":"2015","journal-title":"Hum Reprod Update"},{"issue":"(2)","key":"10.1016\/j.ijgo.2015.11.006-BIB0080|rf0080","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.contraception.2014.04.011","article-title":"Effect of oral administration of a continuous 18 day regimen of meloxicam on ovulation: experience of a randomized controlled trial","volume":"90","author":"Jesam","year":"2014","journal-title":"Contraception"},{"issue":"(1)","key":"10.1016\/j.ijgo.2015.11.006-BIB0085|rf0085","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1093\/aje\/kwi162","article-title":"Short-term oral contraceptive use and the risk of epithelial ovarian cancer","volume":"162","author":"Greer","year":"2005","journal-title":"Am J Epidemiol"},{"issue":"(1)","key":"10.1016\/j.ijgo.2015.11.006-BIB0090|rf0090","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1097\/AOG.0b013e318291c235","article-title":"Oral contraceptive pills as primary prevention for ovarian cancer: a systematic review and meta-analysis","volume":"122","author":"Havrilesky","year":"2013","journal-title":"Obstet Gynecol"},{"issue":"(11)","key":"10.1016\/j.ijgo.2015.11.006-BIB0095|rf0095","doi-asserted-by":"crossref","first-page":"2825","DOI":"10.1093\/humrep\/17.11.2825","article-title":"Follicular administration of a cyclooxygenase inhibitor can prevent oocyte release without alteration of normal luteal function in rhesus monkeys","volume":"17","author":"Duffy","year":"2002","journal-title":"Hum Reprod"},{"issue":"(5)","key":"10.1016\/j.ijgo.2015.11.006-BIB0100|rf0100","doi-asserted-by":"crossref","first-page":"376","DOI":"10.7326\/0003-4819-146-5-200703060-00010","article-title":"Nonsteroidal anti-inflammatory drugs and cyclooxygenase-2 inhibitors for primary prevention of colorectal cancer: a systematic review prepared for the U.S. Preventive Services Task Force","volume":"146","author":"Rostom","year":"2007","journal-title":"Ann Intern Med"},{"issue":"(4)","key":"10.1016\/j.ijgo.2015.11.006-BIB0105|rf0105","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1158\/1055-9965.EPI-14-1128","article-title":"Population distribution of lifetime risk of ovarian cancer in the United States","volume":"24","author":"Pearce","year":"2015","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"(9255)","key":"10.1016\/j.ijgo.2015.11.006-BIB0110|rf0110","first-page":"439","article-title":"Inflammation and cancer: back to Virchow?","volume":"357","author":"Balkwill","year":"2001","journal-title":"Lancet"},{"issue":"(5)","key":"10.1016\/j.ijgo.2015.11.006-BIB0115|rf0115","doi-asserted-by":"crossref","first-page":"347","DOI":"10.7326\/M15-0039","article-title":"Low-dose aspirin or non-steroidal anti-inflammatory drug use and colorectal cancer risk: a population-based, case-control study","volume":"163","author":"Friis","year":"2015","journal-title":"Ann Intern Med"},{"issue":"(2)","key":"10.1016\/j.ijgo.2015.11.006-BIB0120|rf0140","article-title":"Aspirin, nonaspirin nonsteroidal anti-inflammatory drug, and acetaminophen use and risk of invasive epithelial ovarian cancer: a pooled analysis in the Ovarian Cancer Association Consortium","volume":"106","author":"Trabert","year":"2014","journal-title":"J Natl Cancer Inst"},{"issue":"(4)","key":"10.1016\/j.ijgo.2015.11.006-BIB0125|rf0120","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1093\/annonc\/mdu578","article-title":"Low-dose aspirin use and the risk of ovarian cancer in Denmark","volume":"26","author":"Baandrup","year":"2015","journal-title":"Ann Oncol"},{"issue":"(11)","key":"10.1016\/j.ijgo.2015.11.006-BIB0130|rf0125","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1007\/s10552-012-0063-2","article-title":"Non-steroidal anti-inflammatory drug use and ovarian cancer risk: findings from the NIH-AARP Diet and Health Study and systematic review","volume":"23","author":"Murphy","year":"2012","journal-title":"Cancer Causes Control"},{"issue":"(3)","key":"10.1016\/j.ijgo.2015.11.006-BIB0135|rf0130","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/j.ygyno.2013.05.018","article-title":"Long term consumption of flaxseed enriched diet decreased ovarian cancer incidence and prostaglandin E2 in hens","volume":"130","author":"Eilati","year":"2013","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ijgo.2015.11.006-BIB0140|rf0135","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1186\/1476-511X-12-152","article-title":"Anti-inflammatory effects of fish oil in ovaries of laying hens target prostaglandin pathways","volume":"12","author":"Eilati","year":"2013","journal-title":"Lipids Health Dis"}],"container-title":["International Journal of Gynecology & Obstetrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S0020729215007389?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S0020729215007389?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1016%2Fj.ijgo.2015.11.006","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1016%2Fj.ijgo.2015.11.006","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1016\/j.ijgo.2015.11.006\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,23]],"date-time":"2017-06-23T23:19:17Z","timestamp":1498259957000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1016\/j.ijgo.2015.11.006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1,8]]},"references-count":28,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,3]]}},"URL":"https:\/\/doi.org\/10.1016\/j.ijgo.2015.11.006","archive":["Portico"],"relation":{},"ISSN":["0020-7292"],"issn-type":[{"value":"0020-7292","type":"print"}],"subject":[],"published":{"date-parts":[[2016,1,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Non-hormonal interruption of incessant ovulation as a potential approach for ovarian cancer prevention","name":"articletitle","label":"Article Title"},{"value":"International Journal of Gynecology & Obstetrics","name":"journaltitle","label":"Journal Title"},{"value":"http:\/\/dx.doi.org\/10.1016\/j.ijgo.2015.11.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 International Federation of Gynecology and Obstetrics. Published by Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}